NOVEL TETRAHETEROCYCLE COMPOUND

The present invention relates to a novel tetraheterocycle compound and, more specifically, to a novel tetraheterocycle compound useful as a KRAS protein inhibitor, an isomer, and a pharmaceutical composition for cancer treatment comprising same. La présente invention concerne un nouveau composé tétr...

Full description

Saved in:
Bibliographic Details
Main Authors PARK, Jong Seon, HONG, Soo Jung, LEE, Jung Woo, KIM, Jin Woong, HONG, Sung Jun, PARK, Joon Tae, HONG, Chang Hee, LEE, Jin Hee, LEE, Joo Yun, AN, Kyung Mi, YOON, Hong Chul
Format Patent
LanguageEnglish
French
Korean
Published 28.03.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a novel tetraheterocycle compound and, more specifically, to a novel tetraheterocycle compound useful as a KRAS protein inhibitor, an isomer, and a pharmaceutical composition for cancer treatment comprising same. La présente invention concerne un nouveau composé tétrahétérocyclique et, plus particulièrement, un nouveau composé tétrahétérocyclique utile en tant qu'inhibiteur de la protéine KRAS, un isomère, et une composition pharmaceutique destinée au traitement du cancer le contenant. 본 발명은 신규한 테트라헤테로사이클 화합물에 관한 것으로, 보다 구체적으로는 KRAS 단백질 저해제로서 유용한 신규한 테트라헤테로사이클 화합물, 이성질체, 및 이를 포함하는 암 치료를 위한 약학적 조성물에 관한 것이다.
Bibliography:Application Number: WO2023KR14444